Addressing Estrogen Deficiency Skin Aging: A Non-Hormonal Approach
Here is an insightful new study featured in the JDD!
Intrinsic skin aging associated with estrogen deficiency presents a distinct therapeutic challenge for dermatology providers. The withdrawal of estrogen accelerates dermal collagen loss, compromises skin hydration, and diminishes elasticity. While systemic hormone replacement can mitigate these cutaneous changes, a significant portion of premenopausal and postmenopausal women are either medically ineligible for or choose against systemic hormonal therapies.
A prospective observational case series published in the Journal of Drugs in Dermatology investigated an alternative non-hormonal treatment strategy. Researchers evaluated the clinical efficacy of injectable non-animal stabilized hyaluronic acid (NASHA) gel skinboosters in premenopausal and postmenopausal women presenting with mild-to-moderate climacteric symptoms and skin aging who were not receiving hormone therapy.
Participants completed three monthly treatment sessions with injectable NASHA gel skinbooster, with multi-modal evaluations conducted over six months. Clinical assessments, standardized high-resolution photography, and validated patient satisfaction metrics tracked changes in facial hydration, elasticity, fine line density, and structural texture across four distinct time points.
The observational data revealed progressive clinical improvements across key skin quality parameters, accompanied by favorable tolerance and high rates of self-reported patient satisfaction.
Review the complete clinical protocol, follow-up findings, and aesthetic outcomes to determine if this non-hormonal intervention fits into your aesthetic dermatology workflow. Read the full article in the latest issue of the Journal of Drugs in Dermatology.
Blog write-up assisted by AI
